Molecular pathogenesis of progression and recurrence in breast phyllodes tumors

American Journal of Translational Research

Volumn 1, Issue 1, 2009, Pages 23-34

  Jara Lazaro, Ana Richelia ^a   Tan, Puay Hoon ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Biological markers; Epithelial stromal interactions; Genetic alterations; Molecular pathogenesis; Phyllodes tumors; Subclones

Indexed keywords

APC PROTEIN; BETA CATENIN; CD34 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; HEPARAN SULFATE; KI 67 ANTIGEN; MYC PROTEIN; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN MLH1; PROTEIN P53; SOMATOMEDIN B; SOMATOMEDIN C; STEM CELL FACTOR RECEPTOR; WNT PROTEIN;

BASE MISPAIRING; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER RECURRENCE; CHROMOSOME 12Q; CHROMOSOME 13Q; CHROMOSOME 15; CHROMOSOME 1Q; CHROMOSOME 5; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CYSTOSARCOMA PHYLLOIDES; EPITHELIUM STROMAL INTERACTION; FIBROADENOMA; GENE DELETION; GENE IDENTIFICATION; GENE LOCUS; GENE OVEREXPRESSION; GENE TRANSLOCATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; REVIEW; SIGNAL TRANSDUCTION; TISSUE INTERACTION;

PHYLLODES;

EID: 77953398255     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Tavassoli FA, Devilee P, editors. World Health Organization Classification of Tumors. Pathogenesis and Genetics of Tumors of the Breast and Female Genital Tract. IARC Press: Lyon 2003.
2. Tan PH, Jayabaskar T, Chuah KL, Lee, HY, Tan Y, Hilmy M, Hung H, Selvarajan S, Bay BH. Phyllodes tumors of the breast. The role of pathologic parameters. Am J Clin Pathol 2005; 123: 529-540.
3. Rosen PP. Fibroepithelial Neoplasms. In Rosen PP. Rosen's Breast Pathology, 3rd edition. Lippincott Williams and Wilkins 2009: p. 187-229.
4. Tavassoli FA. Biphasic tumors. In: Tavassoli FA. Pathology of the Breast. 2nd edition. Appleton and Lange 1999: p. 598-613.
5. Noguchi S, Motomura S, Inaji H, Imaoka S, Koyama H. Clonal analysis of fibroadenoma and phyllodes tumor of the breast. Cancer Res 1993; 53: 4071-4074.
6. Noguchi S, Yokouchi H, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H. Progression of fibroadenoma to phyllodes tumor demonstrated by clonal analysis. Cancer 1995; 76: 1779-85.
7. Sawyer, EJ, Hanby AM, Ellis P, Lakhani SR, Ellis IO, Boyle S, Tomlinson IPM. Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components. Am J Pathol 2000; 156(3): 1093-1098.
8. Kleer CG, Giordano TJ, Braun T, Oberman HA. Pathologic, immunohistochemical, molecular features of benign and malignant phyllodes tumors of the breast. Mod Pathol 2001; 14: 185-190.
9. Lae M, Vincent-Salomon A, Savignoni A, Huon I, Freneaux P, Sigal-Zafrani B, Aurias A, Sastre-Garau X, Couturier J. Phyllodes tumors of the breast segregate in two groups according to genetic criteria. Mod Pathol 2007; 20: 435-444.
10. Sawhney N, Garrahan N, Douglas-Jones AG, Williams ED. Epithelial-stromal interactions in tumors. A morphologic study of fibroepithelial tumors of the breast. Cancer 1992; 70: 2115-2120.
11. Sawyer EJ, Hanby AM, Rowan AJ, Gillett CE, Thomas RE, Poulsom R, Lakhani SR, Ellis IO, Ellis P, Tomlinson IP. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumors. J Pathol. 2002; 196: 437-44.
12. Sawyer EJ, Hanby AM, Pousom R, Gillett JR, Ellis IO, Ellis P, Tomlinson IP. Beta-catenin abnormalities and associated insulin-like growth factor overexpression are important in phyllodes tumors and fibroadenomas of the breast. J Pathol 2003; 200: 627-632.
13. Tse GM, Lee CS, Kung FY. Hormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumour: a multicenter study of 143 cases. Am J Clin Pathol 2002; 118: 522-526.
14. Esposito NN, Mohan D, Brufsky A, Lin Y, Kapali M, Dabbs DJ. Phyllodes tumor. A clinicopathologic and immunohistochemical study of 30 cases. Arch Pathol Lab Med 2006; 130: 1516-1521.
15. Tan PH, Jayabaskar T, Yip G, Tan Y, Hilmy M, Selvarajan S, Bay BH. P53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study. Mod Pathol 2005; 18: 1527-1534.
16. Tse GM, Tan PH. Recent advances in the pathology of fibroepithelial tumors of the breast. Curr Diagn Pathol 2005; 11: 426-434.
17. Millar EK, Beretov J, Marr P, Sarris M, Clarke Ra, Kearseley JH, Lee CS. Malignant phyllodes tumors of the breast display increased stromal p53 protein expression. Histopathology 1999; 34: 491-6.
18. Niezabitowski A, Lackowska B, Rys J, et al. Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases. Breast Cancer Res Treat 2001; 65: 77-85.
19. Tse GMK, Lui PC, Vong JS, et al. Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors. Breast Cancer Res Treat 2008.
20. Oda K, Matsuoka Y, Funahashi A, Kitano H. A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol 2005; 1: 2005.0010.
21. Kersting C, Arno Kuijper A, Schmidt H, Packeisen J, Liedtke C, Nicola Tidow N, Gustmann C, Hinrichs B, Wülfing P, Tio J, Boecker W, van Diest P, Brandt B Buerger H. Amplifications of the epidermal growth factor receptor gene (EGFR) are common in phyllodes tumors of the breast and are associated with tumor progression. Lab Invest 2006; 86: 54-61.
22. Tse GMK, Putti TC, Lui PCW, Lo, AWI, Scolyer RA, Law BKB, Karim R, Lee CS. Increased c-kit (CD117) expression in malignant mammary phyllodes tumors. Mod Pathol 2004; 17:827-831.
23. Carvalho s, Silva AO, Milanezi F, Ricardo S, Leitao D, Amendoeira I, Shmitt FC. C-kit and PDGFRA in breast phyllodes tumors: overexpression without mutations? J Clin Pathol 2004; 57: 1075-1079.
24. Chen CM, Chen CJ, Chang CL, Shyu JS, Hsieh HF, Harn HJ. CD34, CD117, and actin expression in phyllodes tumor of the breast. J Surg Res 2000; 94:84-91.
25. Tse GM, Ma TK, Chan KF, Law BK, Chen MH, Li KH, Chan EC, Mak MK. Increased microvessel density in malignant and borderline mammary phyllodes tumors. Histopathology 2001; 38: 567-70.
26. Tse GMK, Lui PCW, Lee CS, et al. Stromal expression of vascular endoethelial growth factor correlates with tumor grade and microvessel density in mammary phyllodes tumors: a multicenter study of 185 cases. Hum Pathol 2004; 35 (9): 1053-7.
27. Koo CY, Bay BH, Lui C-W, Tse GMK, Tan PH, Yip GWC. Immunohistochemical expression of heparin sulfate correlates with stromal cell proliferation in breast phyllodes tumors. Mod Pathol 2006; 19: 1344-1350.
28. Jones AM, Springall R, Graham T, Winter E, Gillett C, Hanby AM, The Phyllodes Tumour Consortium, Tomlinson IPM, Sawyer EJ. A comprehensive genetic profile of phyllodes tumors of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence. J Pathol 2008; 214:533-544.
29. Jones AM, Mitter R, Poulsom R, Gillett C, Hanby AM, Phyllodes Tumour Consortium, Tomlinson IPM, Sawyer EJ. mRNA expression profiling of phyllodes tumours of the breast: identification of genes important in the development of borderline and malignant phyllodes tumours. J Pathol 2008; 216: 408-417.